Correspondence of Plasma and salivary cortisol patterns in women with breast cancer

Neuroendocrinology

Volumn 100, Issue , 2014, Pages 153-161

  Zeitzer, Jamie M ^a,b   Nouriani, Bita ^a   Neri, Eric ^a   Spiegel, David ^a  

^a STANFORD UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Circadian rhythm; Cortisol; Diurnal rhythm; Plasma; Saliva; Sleep; Women

Indexed keywords

HYDROCORTISONE;

ADULT; ADVANCED CANCER; AGED; AROUSAL; ARTICLE; BREAST CANCER; CIRCADIAN RHYTHM; CONTROLLED STUDY; CURVE FITTING; DIURNAL SLOPE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; SALIVA LEVEL; SLEEP; SLOPE STEEPNESS; SPIKE; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; WAKEFULNESS; BLOOD ANALYSIS; BREAST TUMOR; COHORT ANALYSIS; METABOLISM; PATHOPHYSIOLOGY; PHOTOPERIODICITY; PHYSIOLOGY; SALIVA; STATISTICAL MODEL;

AGED; BLOOD CHEMICAL ANALYSIS; BREAST NEOPLASMS; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; HYDROCORTISONE; LINEAR MODELS; MIDDLE AGED; PHOTOPERIOD; SALIVA; WAKEFULNESS;

EID: 84922409370     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000367925     Document Type: Article

References (43)

1. Stone AA, Schwartz JE, Smyth J, Kirschbaum C, Cohen S, Hellhammer D, Grossman S: Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology 2001; 26: 295-306.
2. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 994-1000.
3. Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D: Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004; 29: 1082-1092.
4. Schrepf A, Clevenger L, Christensen D, Degeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA III, Ganjei-Azar P, Mendez L, Markon K, Lubaroff DM, Thaker PH, Slavich GM, Sood AK, Lutgendorf SK: Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav Immun 2013; 30(suppl):S126-S134.
5. Sephton SE, Lush E, Dedert EA, Floyd AR, Rebholz WN, Dhabhar FS, Spiegel D, Salmon P: Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun 2013; 30(suppl):S163-S170.
6. Cohen S, Schwartz JE, Epel E, Kirschbaum C, Sidney S, Seeman T: Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom Med 2006; 68: 41-50.
7. Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S: Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 2006; 31: 312-324.
8. Stetler C, Dickerson SS, Miller GE: Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression. Psychoneuroendocrinology 2004; 29: 1250-1259.
9. Van der Vegt EJ, van der Ende J, Kirschbaum C, Verhulst FC, Tiemeier H: Early neglect and abuse predict diurnal cortisol patterns in adults. A study of international adoptees. Psychoneuroendocrinology 2009; 34: 660-669.
10. Lasikiewicz N, Hendrickx H, Talbot D, Dye L: Exploration of basal diurnal salivary cortisol profiles in middle-Aged adults: associations with sleep quality and metabolic parameters. Psychoneuroendocrinology 2008; 33: 143-151.
11. Czeisler CA, Klerman EB: Circadian and sleep-dependent regulation of hormone release in humans. Rec Prog Hormone Res 1999; 54: 97-132.
12. Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J: Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 1983; 56: 352-358.
13. Kirschbaum C, Hellhammer DH: Salivary cortisol; in Fink G (ed): Encyclopedia of Stress. San Diego, Academic Press, 2000, vol 3, pp 379-383.
14. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL: Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005; 30: 92-100.
15. Vedhara K, Tuinstra J, Miles JN, Sanderman R, Ranchor AV: Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls. Psychoneuroendocrinology 2006; 31: 299-311.
16. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer; in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949, pp 191-205.
17. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollack CP: The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26: 342-392.
18. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990; 51: 241-247.
19. Halberg F, Johnson EA, Nelson W, Runge W, Sothern RB: Autorhythmometry-procedures for physiologic self-measurements and their analysis. Physiol Teacher 1972; 7: 1-11.
20. Dijk DJ, Duffy JF, Silva EJ, Shanahan TL, Boivin DB, Czeisler CA: Amplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humans. PLoS One 2012; 7:e30037.
21. Chakraborty A, Krzyzanski W, Jusko WJ: Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinetics Biopharm 1999; 27: 23-43.
22. Klerman EB, Gershengorn HB, Duffy JF, Kronauer RE: Comparisons of the variability of three markers of the human circadian pacemaker. J Biol Rhythms 2002; 17: 181-193.
23. Zeitzer JM, Dijk D-J, Kronauer RE, Brown EN, Czeisler CA: Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000; 526: 695-702.
24. Kraemer HC, Giese-Davis J, Yutsis M, O'Hara R, Neri E, Gallagher-Thompson D, Taylor CB, Spiegel D: Design decisions to optimize reliability of daytime cortisol slopes in an older population. Am J Geriatr Psychiatry 2006; 14: 325-333.
25. Adam EK, Kumari M: Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 2009; 34: 1423-1436.
26. Duffy JF, Dijk D-J: Getting through to circadian oscillators: why use constant routines? J Biol Rhythms 2002; 17: 4-13.
27. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2010.
28. Zeitzer JM, David R, Friedman L, Mulin E, Garcia R, Wang J, Yesavage JA, Robert PH, Shannon W: Phenotyping apathy in individuals with Alzheimer disease using functional principal component analysis. Am J Geriatr Psychiatry 2013; 21: 391-397.
29. Ramsay JO, Silverman BW: Functional Data Analysis, ed 2. New York, Springer, 2005.
30. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C: Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997; 61: 2539-2549.
31. Pruessner JC, Hellhammer DH, Kirschbaum C: Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 1999; 61: 197-204.
32. Wust S, Federenko I, Hellhammer DH, Kirschbaum C: Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000; 25: 707-720.
33. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP: Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-Adrenal axis: clinical implications. J Clin Endocrinol Metab 2001; 86: 3787-3794.
34. Vgontzas AN, Zoumakis M, Bixler EO, Lin HM, Prolo P, Vela-Bueno A, Kales A, Chrousos GP: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003; 88: 2087-2095.
35. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ: Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996; 40: 79-88.
36. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, Van Cauter E: The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985; 61: 429-438.
37. Murphy BEP: Corticosteroid-binding globulin (transcortin); in Fink G (ed): Stress Science: Neuroendocrinology. San Francisco, Elsevier, 2010, pp 245-252.
38. Bell E, Bulbrook RD, Deshpande N: Transcortin in the plasma of patients with breast cancer. Lancet 1967; 290: 395-397.
39. Löfgren L, Wallberg B, Wilking N, Fornander T, Rutqvist LE, Carlstrom K, von Schoultz B, von Schoultz E: Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. Med Oncol 2004; 21: 309-318.
40. Smyth JM, Ockenfels MC, Gorin AA, Catley D, Porter LS, Kirschbaum C, Hellhammer DH, Stone AA: Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 1997; 22: 89-105.
41. Weinrib AZ, Sephton S, Degeest K, Penedo F, Bender D, Zimmerman B, Kirschbaum C, Sood AK, Lubaroff DM, Lutgendorf SK: Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer 2010; 116: 4410-4419.
42. Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JMG, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L: Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 2012; 7:e42324.
43. Spiegel D, Giese-Davis J, Taylor CB, Kraemer H: Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-Adrenal axis function. Psychoneuroendocrinology 2006; 31: 1231-1244.